These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33492397)

  • 1. Central sensitization, illness perception and obesity should be considered when interpreting disease activity in axial spondyloarthritis.
    Kieskamp SC; Paap D; Carbo MJG; Wink F; Bos R; Bootsma H; Arends S; Spoorenberg A
    Rheumatology (Oxford); 2021 Oct; 60(10):4476-4485. PubMed ID: 33492397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central sensitization has major impact on quality of life in patients with axial spondyloarthritis.
    Kieskamp SC; Paap D; Carbo MJG; Wink F; Bos R; Bootsma H; Arends S; Spoorenberg A
    Semin Arthritis Rheum; 2022 Feb; 52():151933. PubMed ID: 35033996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsychosocial factors should be considered when evaluating central sensitization in axial spondyloarthritis.
    Sariyildiz A; Coskun Benlidayi I; Turk I; Zengin Acemoglu SS; Unal I
    Rheumatol Int; 2023 May; 43(5):923-932. PubMed ID: 36966430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients' Perspectives on Axial Pain in Relation to Inflammation and Structural Damage in a Large Cohort of Axial Spondyloarthritis Patients.
    Kampman A; Wink F; Paap D; Carbo M; Siderius M; Kieskamp S; Maas F; Spoorenberg A; Arends S
    Arthritis Care Res (Hoboken); 2024 Mar; 76(3):350-358. PubMed ID: 37781730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between central sensitization and disease activity, quality of life, and sleep quality among patients with axial spondyloarthritis.
    Aykurt Karlıbel I; Kasapoğlu Aksoy M
    Ir J Med Sci; 2023 Feb; 192(1):481-489. PubMed ID: 35226249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of physical activity are associated with less evasive coping, better physical function and quality of life in patients with axial spondyloarthritis.
    Carbo M; Paap D; van Overbeeke L; Wink F; Bootsma H; Arends S; Spoorenberg A
    PLoS One; 2024; 19(5):e0301965. PubMed ID: 38758932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central Sensitization in Spondyloarthritis: The Crossroads between Disease Activity, Health-related Quality of Life and Fibromyalgia.
    Aicha BT; Ines C; Olfa S; Selma B; Leila R; Rawdha T; Ines M; Leila A
    Curr Rheumatol Rev; 2023; 19(4):479-487. PubMed ID: 36974408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue in patients with spondyloarthritis associates with disease activity, quality of life and inflammatory bowel symptoms.
    Stebbings SM; Treharne GJ; Jenks K; Highton J
    Clin Rheumatol; 2014; 33(10):1467-74. PubMed ID: 24322832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary definitions of 'flare' in axial spondyloarthritis, based on pain, BASDAI and ASDAS-CRP: an ASAS initiative.
    Gossec L; Portier A; Landewé R; Etcheto A; Navarro-Compán V; Kroon F; van der Heijde D; Dougados M
    Ann Rheum Dis; 2016 Jun; 75(6):991-6. PubMed ID: 26847821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of spondylarthritis activity by patients and physicians: ASDAS, BASDAI, PASS, and flares in 200 patients.
    Godfrin-Valnet M; Prati C; Puyraveau M; Toussirot E; Letho-Gyselink H; Wendling D
    Joint Bone Spine; 2013 Jul; 80(4):393-8. PubMed ID: 23453478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring pain catastrophizing and its associations with low disease activity in rheumatic inflammatory disorders.
    Wilk M; Pripp AH; Korkosz M; Haugeberg G
    Rheumatol Int; 2023 Apr; 43(4):687-694. PubMed ID: 36624289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High prevalence of hidradenitis suppurativa symptoms in axial spondyloarthritis patients: A possible new extra-articular manifestation.
    Rondags A; Arends S; Wink FR; Horváth B; Spoorenberg A
    Semin Arthritis Rheum; 2019 Feb; 48(4):611-617. PubMed ID: 29751976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pain catastrophizing negatively impacts drug retention rate in patients with Psoriatic Arthritis and axial Spondyloarthritis: results from a 2-years perspective multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica) study.
    Currado D; Saracino F; Ruscitti P; Marino A; Pantano I; Vomero M; Berardicurti O; Pavlych V; Di Vico C; Caso F; Costa L; Tasso M; Camarda F; Misceo F; De Vincenzo F; Corrado A; Arcarese L; Rigon A; Vadacca M; Corberi E; Kun L; Trunfio F; Pilato A; Lamberti L; Cantatore FP; Perosa F; Guggino G; Scarpa R; Cipriani P; Ciccia F; Giacomelli R; Navarini L
    Arthritis Res Ther; 2024 Sep; 26(1):162. PubMed ID: 39294672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol and disease activity in axial spondyloarthritis: a cross-sectional study.
    Zhao S; Thong D; Duffield SJ; Hughes D; Goodson NJ
    Rheumatol Int; 2018 Mar; 38(3):375-381. PubMed ID: 29322342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity Is Common in Axial Spondyloarthritis and Is Associated with Poor Clinical Outcome.
    Maas F; Arends S; van der Veer E; Wink F; Efde M; Bootsma H; Brouwer E; Spoorenberg A
    J Rheumatol; 2016 Feb; 43(2):383-7. PubMed ID: 26669924
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of obesity on the response to tumor necrosis factor inhibitors in axial spondyloarthritis.
    Micheroli R; Hebeisen M; Wildi LM; Exer P; Tamborrini G; Bernhard J; Möller B; Zufferey P; Nissen MJ; Scherer A; Ciurea A;
    Arthritis Res Ther; 2017 Jul; 19(1):164. PubMed ID: 28724442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Routine Assessment of Patient Index Data 3 score (RAPID3) correlates well with Bath Ankylosing Spondylitis Disease Activity index (BASDAI) in the assessment of disease activity and monitoring progression of axial spondyloarthritis.
    Danve A; Reddy A; Vakil-Gilani K; Garg N; Dinno A; Deodhar A
    Clin Rheumatol; 2015 Jan; 34(1):117-24. PubMed ID: 25421013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminant validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with non-radiographic axial spondyloarthritis and ankylosing spondylitis: a cohort study.
    Kilic E; Kilic G; Akgul O; Ozgocmen S
    Rheumatol Int; 2015 Jun; 35(6):981-9. PubMed ID: 25366469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
    Gossec L; Berenbaum F; Chauvin P; Hudry C; Cukierman G; de Chalus T; Dreuillet C; Saulot V; Tong S; Russo-Marie F; Joubert JM; Saraux A
    Clin Rheumatol; 2018 Oct; 37(10):2649-2657. PubMed ID: 29948351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validity and reliability of the Ankylosing Spondylitis Disease Activity Score with C-reactive protein (ASDAS-CRP) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) in patients with axial spondyloarthritis (axSpA) in Singapore.
    Kwan YH; Tan JJ; Phang JK; Fong W; Lim KK; Koh HL; Lui NL; Tan CS; Østbye T; Thumboo J; Leung YY
    Int J Rheum Dis; 2019 Dec; 22(12):2206-2212. PubMed ID: 31721427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.